ArticleActa diabetologica2025

SGLT-2 inhibitors are beneficial in reducing the risk of thyroid cancer: findings from a Mendelian randomization study.

LiRong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.